KNOWLEDGE BANK

Interviews

Why Do Pharma Construction Projects Need Cost Certainty | Linesight | ISPE Singapore 2026 | Pharma Focus Asia

Associate Director, Project Controls, Linesight
Stephanie Ledwidge is an experienced project controls and cost management professional with expertise across the life sciences and pharmaceutical sectors She currently serves as Associate Director Project Controls at Linesight in Singapore Her experience spans project controls cost engineering project coordination and project delivery with previous roles supporting organisations including CSL Behr...

Articles

Architecting the Modern MICC for Life Sciences GCCs

Imagine a bewilderingly busy therapeutic hub where thousands of messages arrive simultaneously from every corner of the globe Thousands of people hundreds of languages A Medical Information Contact Centre MICC is precisely this the central nervous system for pharmaceutical operations

Research Insights

Analytical and statistical comparability of generic enoxaparins from the US market with the originator product

Abstract Lowmolecularweight heparins LMWHs are complex anticoagulant drugs made from heparin porcine mucosa starting material Enoxaparin sodium manufactured by Sanofi is one of the most widely prescribed LMWHs and has been used since in the USA In US Food and Drug Administration approval for supplying generic enoxaparin was granted to Sandoz and su

Case Studies

Novel Vaccines - Heat Stable Anthrax Vaccine

Challenge Existing approved Anthrax vaccines are based on cellfree filtrates of disintegrated cells of Bacillus anthracis adsorbed onto an aluminiumhydrogel adjuvant A number of side effects are attributed to these vaccines including poor safety profile and a low immunogenicity necessitating repea

Techno Trends

FDA Grants Breakthrough Therapy Designation for PTI-428 in Cystic Fibrosis

The US Food and Drug Administration FDA grants Proteostasis Therapeutics PTI a Breakthrough therapy for the treatment of cystic fibrosis patients with two copies of the Fdel genetic mutation who are receiving Orkambi as background therapy PTI is an investigational CFTR amplifier in the development for treating CF in patients who are homozygous for the Fdel mutation...

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Meet scientist Daria Donati

Daria Donati

Daria’s work is ongoing. Her role at Cytiva involves identifying new and innovative technologies that can help in the development of therapeutics. This means building partnerships, improving manufacturing processes and, ultimately, getting life- saving drugs to the people who need them most.

 

2

Marine Biomaterials for Drug Delivery Applications

Innocent J Macha

Macha has six years of experience in research and teaching in the area of biomaterials synthesis and characterisations, drug delivery devices, cell culture and bacterial biofilm. He is also Associate Editor of the Journal of The Australian Ceramic Society and has published more than 14 articles and 6 book chapters.

3

Current Challenges in Fully Digitising Manufacturing for Biotech and Cell and Gene Therapy Companies

Abhijit Ray

Abhijit has led teams for large enterprises helping them take their performance to the cloud. He has implemented AI/ML solutions, IoT frameworks, and cloud infrastructure.

 

4

Nanotechnology as a Potential Therapeutic Strategy in Breast Cancer Management

Mr. Rahul Pal

Mr. Rahul Pal (Young Scientist), Ass. Prof. Department of Pharmacy, Jagannath University, Jaipur, holds B. Pharm, M. Pharm (Pharmaceutics), and PhD* at Chitkara University. He has authored 50+ publications, 8 textbooks, 12 edited book, secured 38 patents, 3 copyrights, received the Young Researcher Award (2025), and actively contributes as reviewer, editor, and speaker in national and international academic forums.

5

The Rapidly Evolving Landscape of Cancer Therapeutics

Rajesh Kumar

Rajesh Kumar is an Assistant Professor of Pharmaceutical Sciences at Kerala University of Health Sciences, India. He has been teaching Diploma, Bachelor, and Doctor of Pharmacy students for several years and is actively involved in research. He has authored more than 19 papers and is a reviewer for Bentham Science Publishers. His research includes applying the principles of pharmaceutical sciences, omics technologies, computational biology, and bioinformatics in the broad areas of cancer research, ethnopharmacology, drug delivery, targeting, and formulations.

 

Seetha Harilal

Seetha Harilal is an Assistant Professor of Pharmacology at Kerala University of Health Sciences, India. She has several years of experience in teaching Diploma, Bachelor, and Doctor of Pharmacy students and is actively pursuing research. She has authored more than 22 papers and is a manuscript reviewer for Bentham Science Publishers, Frontiers in Public Health, Frontiers in Medicine, and Archives of Medical Research (Elsevier). Her research includes the diverse areas of pharmacology and therapeutics, phytopharmaceuticals, cancer research, neurological disorders, and the application of omics technologies, computational pharmacology, and bioinformatics.

 

press releasesRead more...

Sanofi and 2026 NBA Champion Karl-Anthony Towns team up to raise awareness of COVID-19 vaccination with NUVAXOVID®

Sanofi has partnered with NBA Champion KarlAnthony Towns to help raise awareness about the importance of COVID vaccination among those eligible during the respiratory season

ALK expands strategic tablet supply partnership with Catalent

ALK ALKBDC Nasdaq Copenhagen ALK B today announced that it has expanded its longstanding contract manufacturing partnership with Catalent Inc Catalent a leader in enabling the development

Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month

Piramal Pharma Solutions PPS a leading global Contract Development and Manufacturing Organization CDMO and part of Piramal Pharma Ltd PPL NSE PPLPHARMA BSE

OnDosis and Adare Pharma Solutions Announce Strategic Collaboration to Advance OnDosis's Lead U.S. ADHD Program

OnDosis AB OnDosis a Swedish life science company developing drug device combinations for precision dosing of oral solid medicines based on the Dosage Manager device platform and Adare Pharma

Expert Shares Why ADC Development is Demanding a New Level of Bioconjugation Expertise

Antibodydrug conjugates have moved from a promising concept to one of the most actively developed drug classes in oncology Behind that progress lies a manufacturing challenge that is becoming more demanding by the year

Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596

Hengrui Pharma SH HK today announced that it has entered into a license agreement with Novo Nordisk Novo for HRS a phase Iready glucagonlike peptide receptor GLPR

EventsRead more...

05 - 06

Oct 2026

ISPSAI France 2026

Paris, France

05 - 08

Oct 2026

12 - 13

Oct 2026

Pharmaceutics 2026

Village Hotel Changi, Singapor...

12 - 13

Oct 2026

2nd International Conference on Drug Discovery

Village Hotel Changi, Singapor...

14 - 15

Oct 2026

PDA Aseptic Manufacturing Excellence Conference

Pullman East Melbourne, Austra...

21 - 23

Oct 2026

21 - 22

Oct 2026

22 - 23

Oct 2026

PDA Aseptic Symposium 2026

Congress Square Nakanoshima, O...

LATEST NEWSRead more...

Regeneron and Sanofi Expand Collaboration to Develop Long-Acting Immunology Antibodies

Regeneron Pharmaceuticals and Sanofi have expanded their longstanding antibody collaboration to develop and commercialise a new group of longacting immunology treatments

SK pharmteco Announces $200 Million Investment to Expand Manufacturing Capacity

SK pharmteco has announced a fiveyear investment of more than million to expand and upgrade its development and manufacturing capabilities in the US focusing on small molecules and peptides

CAS and Novartis Collaborate to Advance AI-Ready Reaction Data

CAS has announced a collaboration with Novartis Biomedical Research to improve access to reaction data and support the use of artificial intelligence in scientific research

AbbVie Partners with Valkai to Expand AI Use in Clinical Development

AbbVie has partnered with Valkai to expand the use of AI across selected areas of clinical development

Turbine and Daiichi Sankyo Expand ADC Discovery Collaboration

Turbine and Daiichi Sankyo have expanded their collaboration to support antibodydrug conjugate ADC discovery using computational modelling

TriSalus Receives FDA Clearance for TriNav Advance for Liver Embolisation

TriSalus Life Sciences has received k clearance from the US Food and Drug Administration FDA for TriNav Advance a new device within its PressureEnabled Drug Delivery PEDD portfolio for liverdirected embolisation procedures